EVENT GUIDE
The 2025 Program Allowed Attendees to:
3 days packed full of high-quality talks from Novo Nordisk, Eli Lilly & Co, Roche, Altimmune, Neuraly, Biolexis Therapeutics, Regeneron and more…
Expert-led, ‘deep dive’ Worksop day into advancing understanding of GLP-1 mechanisms for the discovery and development of combination therapies and enhanced therapeutic design
6+ hours of dedicated networking sessions
Brand new preclinical and clinical data from Eli Lilly & Co., Novo Nordisk, Roche, Altimmune, Biolexis Therapeutics, and more
18+ Expert speakers form Regeneron, American Diabetes Association, Neuraly and more!
Having issues downloading? Click here to request a copy of the agenda!